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Sm_ry In 96 patients with uveal malignant melanomas the tumours were investigated by DNA flow
cytometry. Thirty-eight per cent of the melanomas were aneuploid. By univariate analysis significant correla-
tions with survival were found for histological type, tumour size, DNA ploidy, evidence of 'blind eye' and
S-phase fraction. By multivariate analysis, significant prognostic variables were found to be histological type
(P=0.0008), tumour size (P<0.0001) and DNA ploidy (P=0.0038). Evidence of 'blnd eye' was not
significntly corrated with sunrival after adjustments for the other variabls mentioned above. The S-phase
fraction could be estimated m all 60 diploid tumours and in 12 of 36 aneuploid melanomas. By univariate
analysis this variable was found to be a significant prognostic factor, but did not remain so after adjustment
for ploidy, histological type and tumour size. We further conclude that patients with small DNA diploid uveal
melanomas of spindle cell type have a rather favourable prognoss.
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Malignant melanoma in the eye is the most common primary
intraocular malignancy in human adults (Swerdlow, 1983),
and poses a serious threat to both sight and survival. App-
roximately half ofpatients with uveal melanoma die from the
disease within 10-15 years after enucleation of the eye
(Jensen et al., 1982; Raivio, 1977), and deaths from metas-
tases have been observed up to 30 years after diagnosis. The
melanoma may arise from a variety of ocular tissues, most of
the ocular melanomas being located to the uvea. A majority
of the uveal melanomas are found in the choroid (85%), and
a smaller number are found in the ciliary body (10%) and
the iris (5%) (Raivio, 1977). Conjunctival melanomas are
uncommon, accounting for 2% of all eye tumours (Rennie,
1991).
The survival of the patient is longer when the melanoma
arises in the iris or conjunctiva than in the ciliary body or the
choroid (Hungerford, 1989; Seregard and Kock, 1992). How-
ever, it is well recognised that the metastatic potential varies
from tumour to tumour; some give rise to early metastases
whereas others never metastasise. In earlier studies prognos-
tic variables such as age, tumour size, location, invasion into
the sclera or optic nerve, blind eye, cell type, rupture of
Bruch's membrane and extrascleral extension of the tumour
were found to predict survival in patients with uveal
melanomas (Callender et al., 1941; Raivio, 1977; Affeldt et
al., 1980; Pach et al., 1986; Hungerford, 1989; Gamel et al.,
1992). To some extent this was also the case with conjunc-
tival melanomas (Fuchs et al., 1989).
DNA ploidy and S-phase fraction are important variables
for the prediction of survival of patients with cutaneous
malignant melanoma. This was demonstrated with both
primary melanomas (Kheir et al., 1988) and melanoma
metastases (Sondergaard et al., 1983). To some extent flow
cytometric analyses have also been applied to ocular malig-
nant melanomas. Only three studies have tried to correlate
DNA ploidy and S-phase fraction with survival, and with
contradictionary results. Thus, in a study on 64 uveal
melanomas Meecham and Char (1986) found that hyper-
ploidy was correlated with a poor prognosis. In contrast,
Shapiro et al. (1986), in a study of 36 uveal melanomas, were
unable to detect any association between a high DNA
(ploidy) index and death from metastatic disease. In a step-
wise analysis when both the standard deviation of the
nucleolar area and the largest dimension of the tumour were
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entered, McLean and Gamel (1988) found that the chi-square
value for DNA amount in the cell dropped to a non-
significant level. Rennie et al. (1989) measured the sum of S
and G2/M phases in 19 fresh uveal melanomas and found for
diploid tumours that spindle cell neoplasms had lower cell
turnover rates than epithelioid cells.
The aim of the present study was to investigate if DNA
ploidy and S-phase fraction provide prognostic information
in uveal malignant melanomas.
MaterW and
Patients
All new cases of histologically verified eye melanomas from
the years 1971-84 were identified from the files of the Cancer
Registry in the South-East Health Region of Sweden. A total
of 144 cases were found. In 118 cases patient records and
histological matenal recovered from paraffin-embedded speci-
mens were collected from the departments of ophthalmology
of the four. largest hospitals in the region (University Hos-
pital of Linkl6ping, Central Hospital of Norrk6ping and the
County Hospitals in J6nk6ping and Kalmar). Nimety-six
samples could be evaluated by flow cytometry, and these
patients constituted the study population. None of the
patients had demonstrated metastatic disease at presentation,
and they were all treated by enucleation, except the patients
with melanoma of the iris, who were treated by local resec-
tions. Two patients were treated with radiotherapy prior to
enucleation, but no patient received radiotherapy after the
surgery.
There were 44 females and 52 males in the study. The
oldest patient was an 84-year-old man and the youngest a
19-year-old woman. The mean age was 60 years. The patients
were followed until 31 December 1992. Tbirty-eight died
from disseminated malignant melanoma and 20 died from
intercurrent diseases, including one from cancer of the pros-
tate and one from hypernephroma. Thirty-eight were still
alive as of January 1993. The 5 year survival of the 96
patients was 72%, the 10 year survival was 62% and the 15
year survival was 50%. The distribution ofclinical and histo-
pathological variables is given in the first column of Table I.
Histopathology andstaging
All tumour samples were reinvestigated and the melanoma
diagnoses were confirmed by one pathologist (BB). SeveralPno_sc fdlm w i ulWOW 0 ~~~~~~~~~~~~~~~~~M Kar1sson et ai
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histological features and well-known prognostic factors for
uveal melanoma were evaluated for each case. Intraocular
variables included cell type (predominantly spindle, mixed or
predominantly epithelioid), presence of optic nerve invasion,
invasion of the sclera, rupture of Bruch's membrane and
tumour location. The tumour size and tumour extension were
classified according to the International Union Against
Cancer (UICC) classification. Evidence of 'blind eye' was
noted. The criterion for this category was visual acuity less
than 0.1.
Cytometry
In the present paper we have used the same procedure as in
earlier papers (Karlsson et al., 1993, 1994), where more
details can be found. In brief, from the paraffin-embedded
specunens, 50p.m tissue sections with a high density of
tumour cells were deparaffinised in xylene followed by step-
wise hydration in ethanol (99.5%, 95%, 70% and 40%) and
disilled water. The cells were centrifuged at 500g for 10 min.
Enzyme treatment was performed with 0.25% trypsin (T
0134, Sigma), dissolved in citrate buffer (Schutte et al., 1985),
and the samples were incubated overnight in a 37C shaking
water bath. On the next day the trypsin inhibitor T 9253
(Sigma) and RNAse were added. After filtration through a
nylon mesh, the cell suspension was stained with
0.13 mg ml-' propidium iodide (Vindel0v et al., 1983).
We used a FACScan flow cytometer (Becton Dickinson)
and a 15 mW argon laser (488 nm) to excite the propidium
iodide. Histograms with 15,000 events were recorded. The
S-phase fraction was estimated assuming a rectangular dis-
tribution (Baisch et al., 1975) and defined as the area
between GO/GI and G2/M peaks. All S-phase values were
corrected for background as described previously (Karlsson
et al., 1993). The peak with the lowest DNA value was
considered to be diploid. Tumours with a single GO/GI peak
were regarded as diploid, while tumours with one or more
additional peaks were defined as aneuploid. Interpretation of
the DNA histogram was made independently of information
regarding the clinical outcome. In our material the mean
coefficient of variation was 7.8% (s.d. 2.16).
Statistics
Cancer survival curves were estimated according to the
method of Kaplan and Meier (1958). Univariate and multi-
variate survival analyses were performed using the propor-
tional hazards model of Cox (1972). In all survival analyses,
only cancer deaths were considered as uncensored observa-
tions.
Results
In the total material 60 tumours were DNA diploid and 36
were aneuploid. DNA ploidy was correlated to histological
TableI Distribution ofclinical andhistopathologicalvanrablesandtheircorrelationswith DNAploidy
and S-phase fraction
DNA ploidy S-phase fraction
Variable n Aneuploidy (%) n Mean (s.d.)
Sex P=0.53 P=0.96
Female 44 40 38 5.5 (4.2)
Male 52 34 34 5.6 (4.2)
Age (years) P<0.23a P = 0.17r
<49 20 50 14 7.2 (5.8)
50-59 27 37 20 5.4 (4.2)
60-69 24 33 18 5.0 (2.2)
>70 25 32 20 5.0 (4.1)
Site of origin P=0.22 P= 0.75
Choroidea 83 35 64 5.7 (4.3)
Corpus cilares 12 58 7 4.9 (2.3)
iris 1 0 1 3.1 (0)
Histological type P = 0.011' P = 0.004a
Predominantly spindle 40 28 31 3.8 (2.9)
Mixed 42 38 32 6.9 (4.7)
Predominantly epithelioid 13 69 8 7.0 (4.1)
Invasion into the sclera P= 0.13a P= 0.35'
No 21 24 16 6.1 (5.2)
Yes 69 41 51 4.9 (3.6)
Through 6 50 5 10.6 (3.1)
Tumour sizeb P=0.30' P= 0.005'
Tla 16 25 13 5.0 (2.0)
Tlb 32 41 23 4.5 (3.9)
T2 32 38 23 5.1 (4.3)
T3 9 44 7 8.0 (5.5)
T4 6 50 5 10.6 (3.1)
Invasion into nucleus opticus P = 0.18 P = 0.32
No 85 40 61 5.3 (3.8)
Yes 7 14 7 6.9 (5.3)
Ruptured Bruch's membrane P = 0.063 P= 0.40
No 44 27 35 4.8 (3.7)
Yes 43 47 28 5.7 (4.6)
Location in the eye P = 0.39' P = 0.69'
Anterior part 27 48 18 5.4 (3.5)
Posterior part 49 28 39 5.1 (4.2)
Both anterior and posterior
part 15 40 12 6.2 (4.7)
Evidence of 'blind' eye P = 0.040 P = 0.23
No 71 32 54 5.0 (3.7)
Yes 21 57 14 6.4 (3.8)
'Test for trend. bClassification according to UICC.Prpin-cl tfades inuvw --el -aso
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type and evidence of blind' eye so that aneuploid tumours
more often consisted of an epithelioid cell type, and the
patients more frequently had a 'blind' eye (Table I). By
univariate survival analysis histological type (P = 0.0002,
Figure 1), tumour size (P<0.0001, Figure 2) and ploidy
(P<0.0001, Figure 3) were found to be significantly
associated with survival. Evidence of 'blind' eye was also
significantly correlated with survival (P = 0.011). The correla-
tion with survival was such that long survival was associated
with a DNA diploid tumour, small tumour size and a
predominantly spindle cell type (Figures 1-3). None of the
other variables in Table I influenced the prognosis. On mul-
tivariate analysis tumour size, histological type and DNA
ploidy remained significant prognostic factors after adjust-
ment for each other (Table II). Evidence of 'blind eye' was
not significantly correlated with survival after adjustments for
the other variables mentioned above (P = 0.52).
A reliable S-phase fraction was found in 72 melanomas.
The S-phase fraction was reliable in all DNA diploid
tumours, but of 36 aneuploid melanomas only 12 had a
measurable S-phase fraction. The difficulty in estimating a
reliable S-phase fraction in aneuploid tumours mostly
depends on the overlap of the diploid G2/M cells in the
S-phase region of the aneuploid tumour. Aneuploid tumours
tended to have a higher S-phase fraction than diploid ones
(P = 0.001). The mean S-phase fraction for diploid tumours
was 4.9% (s.d. 3.67) and for aneuploid melanomas 9.0% (s.d.
4.91). High S-phase fractions were correlated with an
epithelioid cell type and large tumours (Table I). There was a
significant correlation between S-phase fraction and survival
(P = 0.017, Figure 4), such that low S-phase fraction was
associated with longer survival. However, this correlation
was abolished after adjustment for DNA ploidy (P = 0.16).
Even when restricting the S-phase analysis to diploid cases
only, no significant association was observed between S-
phase fraction and survival.
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Fugwe 1 Relations between survival and histological type in 95
patients with uveal malignant melanoma. Patients with
predominantly spindle cell type (---, n = 40) had a more
favourable prognosis compared with mixed cell type (-, n = 42)
and predominantly epithelioid cell type ( , n = 13)
(P = 0.0002).
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The short-term prognosis of patients with uveal melanomas
is rather favourable, however deaths from metastases may
occur decades after diagnosis. With intraocular melanomas,
as with many other human malignancies, prognosis is cor-
related with tumour size and histological type (Gamel et at.,
1988, 1992; Rennie, 1991). Other well-known prognostic fac-
tors are mentioned in Table I.
Investigations of DNA ploidy in uveal melanomas are
limited, and the few studies have shown contradictory results.
In our study on 96 uveal melanomas, 38% were aneuploid,
which is in line with the findings of Meecham and Char
(1986), who found hyperploidy in 37% of 64 patients with
uveal melanomas. In contrast, Shapiro et al. (1986) found an
aneuploidy rate of 77%, and Rennie et al. (1989) and Cole-
man et al. (1993) detected only 16% and 0% respectively.
However, the last three studies were based on very small
patient numbers, 36, 19 and 19 patients respectively.
Meecham and Char (1986) found that hyperploidy was
correlated with worse outcome. When evaluating prognostic
factors, Meecham and Char (1986) found DNA index, his-
tological type and tumour diameter to be important, but by
multivariate analysis only DNA index was strongly cor-
related with survival. In accordance with this, we found
ploidy together with tumour size and histological type to be
significantly correlated with survival. However, in the mul-
tivariate analysis histological type and tumour size remained
significant even after adjustment for each other and for
ploidy. In contrast, Shapiro et al. (1986) were unable to
detect any association between DNA index and death from
melanoma disease, and McLean and Gamel (1988) did not
find DNA determination to be significantly correlated with
survival after adjustments for the standard deviation of
nucleolar area and measurements of the largest dimension of
the tumour. Although Rennie et al. (1989) believed that
aneuploidy could be correlated with survival, only three of
Fge 2 Survival curves for 95 uveal melanoma patients, sub-
classified according to the UICC classification. The number of
cases were 16 patients with Tla, 32 patients with Tlb or T2, nine
patients with T3 and six patients with T4. The UICC
classification was found to be a significant prognostic vanrable
(P< 0.0001).
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Fge 3 Relations between survival and ploidy in 96 patients
with uveal malignant melanoma. Patients with diploid
melanomas (-, n = 60) had a more favourable prognosis com-
pared with those with aneuploid tumours ( , n = 36)
(P<0.0001).
their patients had died during the short follow-up period,
and obviously no correlations could be found.
In our study the S-phase fraction was significantly cor-
related with survival using univanrate analysis, but the
significance did not remain after adjustment for ploidy. How-
ever, it should be kept in mind that the S-phase fraction
could only be measured in 72 tumours and the drop-out was
only from the aneuploid melanomas. The 12 aneuploid
tumours with measurable S-phase fraction had a significantly
higher S-phase than the diploid ones. Our mean S-phase
fraction was lower than reported by Shapiro et al. (1986),
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Table II Multiple Cox's regression
95%
Relative confidence Test of
Variable n death rate interval significance
Tumour size P<0.0001
tla 16 1.0
tlb 32 2.5 0.5-11.6
t2 32 6.4 1.4-28.9
t3 9 13.9 2.5-75.6
t4 6 17.7 3.0-103.5
Histological type P= 0.0008
Predominantly 40 1.0
spindel cell
Mixed type 42 1.4 0.6-3.1
Predominantly
epithelioid cell 13 7.4 2.7-20.0
DNA ploidy P = 0.0038
Diploid 59 1.0 -
Aneuploid 36 2.9 1.5-5.9
who found that 18% of the uveal melanoma cells were in the
S-phase of the cell cycle. Meecham and Char (1986) com-
pared ploidy measurements from fresh-frozen and paraffin-
embedded samples from the same uveal melanoma and found
that the tumours were identically classified. Jacobsen et al.
(1988) found a strong correlation between ploidy measured in
fresh and paraffin-embedded cutaneous melanomas, while
that of the S-phase fraction was weaker. This may indicate
that the S-phase should be measured on fresh material.
Asessment of proliferation can also be performed on fresh
material by immunological staining of cell cycle-related pro-
teins such as Ki 67 and in paraffin-embedded samples by
cycin (PCNA) (Takahashi et al., 1991; Schwartz et al., 1993).
Thymidine incorporation into DNA during S-phase in
dividing cells also provides information on cell cycle variables
(Char et al., 1989). These variables perhaps are better
markers of proliferation than the S-phase fraction. In order
to find out which method should be preferred, comparison
studies have to be performed.
We found a significant correlation between a high S-phase
fraction and an epithelioid cell type. This is in line with the
findings of Rennie et al. (1989) that spindle cell neoplasms
have lower cell turnover rates than epithelioid cells. However,
they only estimated the cell turnover in 16 diploid tumours,
and no analysis was performed on aneuploid uveal
melanomas. We also found that large tumours had higher
S-phase fractions than small ones. This is in contrast to
Rennie et al. (1989), who found no correlation between cell
turnover and either tumour size or anatomical location.
Evidence of 'blind eye' was earlier described as a poor
prognostic factor for uveal melanomas (Raivio, 1977). We
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Fgwe 4 Survival curves for 72 melanoma patients with the
primary tumour located in the eye, subclassified according to
S-phase of the tumour. The number of cases were 38 patients
with S-phase <5% (---), 26 with S-phase 5.0-9.9% (-) and
eight with S-phase ) 10% ( ). The S-phase was found to be a
significant prognostic variable (P = 0.017).
also found that 'blind eye' is correlated with reduced sur-
vival, but in the multivariate analysis the significance did not
remain after adjustment for tumour size, histological type
and ploidy, perhaps indicating that patients with 'blind eye'
had a larger tumour volume. Ploidy was also significantly
correlated to histological type and evidence of 'blind eye'.
This has not been reported before as far as eye melanomas
are concerned, but correlation between ploidy and his-
tological type, etc., has been seen with cutaneous melanoma
(Guttuso et al., 1990). Fuglestad et al. (1987) found that
tetraploid tumours were associated with increased tumour
size. This is in contrast with our findings of no correlation
between tumour size and ploidy.
We further conclude that patients with small DNA diploid
intraocular melanomas of spindle cell type have a favourable
prognosis. Patients with several risk factors should be more
carefully observed for early detection of disseminated disease.
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